Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
· ·
$262.60
▼ $0.01 (-0.0%)
Market data updated: 09/19 11:09 AM
Fundamentals updated: 09/19/2026
News analyzed: 09/19/2026
Market Cap
Not available
Day Range
$259.62 - $263.55
52-Week Range
$258.61 - $388.71
Beta
—
Next Earnings
27.10.2026
Support
$258.61
Resistance
$356.81
-27.6% (1Y)
Strengths: 8/23 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🟡 Mixed
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Revenue growth (last year)
Revenue growth (last year): 29.5%
Growth
Biggest negative driver
Calmar Ratio (return vs. drawdown)
Calmar: 0.46 (3y annualized return 22.1% / max drawdown 48.2%)
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
51
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
74
Quality
No data available
Value
50
Momentum
6
Risk
48
Sentiment
100
Fundamental
69
Institutional
50
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Evercore Inc. has focused on its cautious third-quarter outlook, with reports highlighting a decline in investment banking and trading activity—including a 6% year-over-year drop in July volumes—while analysts anticipate below-consensus guidance. The firm’s valuation discount to peers may narrow, per Deutsche Bank, while a new senior hire in Europe’s healthcare sector, John Pissanos, could strengthen Evercore’s advisory edge in life sciences and medtech. Additionally, Evercore initiated coverage on Lumentum Holdings, emphasizing its strategic position in AI-driven semiconductor supply chains.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Evercore Inc.. News trend score: 100. Reason: 13 of the last 20 articles are positive, versus 3 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
28
🎯 Conviction (vs. Emotion)
38
Psychology
70
Fundamentals
69
Technical
6
Valuation
50
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
A significant decline over time, but on unusually low trading volume — holders unwilling to accept the loss.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Price (3M)
-29%
Market Narrative
55
Fundamental Reality
38
Narrative Gap
+17
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior for EVR suggests a dominant psychological state of **loss aversion**, as the 3-month price drop (-12.2%) and muted volume activity (0.97x average) indicate investors are hesitant to crystallize losses. While FOMO and panic signals are weak due to neutral momentum and low volatility, the narrative gap (6-point divergence) hints at a disconnect between investor expectations and current fundamentals. The key question is whether the subdued volume reflects strategic holding or a delayed reaction to underlying concerns. The absence of extreme states like euphoria or herding implies a cautious, risk-averse stance rather than herd-driven behavior.
Updated: 09/09/2026, 04:58 AM
What could change this?
👥 What the crowd believes
"John Pissanos has joined Evercore as senior managing director in healthcare investment banking, bringing 15 years of EMEA life science tools and diagnostics experience from J.P. Morgan."
"Evercore anticipates investment banking and trading guidance to come in below consensus estimates due to softer capital markets indicators."
"Deutsche Bank notes Evercore's valuation discount to peers could narrow."
"Evercore initiates Lumentum Holdings at Outperform, citing AI-driven demand for Indium Phosphide lasers and supply-chain bottlenecks."
📈 10D Investor Psychology
Signal classification confidence: Medium (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Peter Lynch — 100/100
🔴 Weakest match
Morgan Housel — 18/100
🗣️ Why do they disagree?
This stock sparks a sharp divide between growth-oriented and value-driven methodologies. Peter Lynch and Edgar Lawrence Smith both rate it near-perfectly, seeing it as a long-term growth opportunity where the price hasn’t yet reflected its potential—Smith even calls it a ‘buy and hold for a decade’ candidate. Meanwhile, Fisher, Schwager, and Marks (in multiple frameworks) agree it’s a disciplined, high-quality play with favorable risk/reward, though their scores dip slightly below the top-tier growth investors. On the other end, Benjamin Graham and Morgan Housel reject it outright, with Graham calling it unsafe by his defensive standards and Housel flagging volatility that could deter patient investors. The contrast highlights a core tension: growth hunters like Lynch and Smith see untapped upside, while value purists like Graham and Housel prioritize stability and margin of safety.
Peter Lynch
One Up on Wall Street (1989)
🟢 100
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 100
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 100
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟢 84
A real, disciplined setup with favorable reward/risk
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟢 81
Growth appears aligned with real value creation
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 80
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟢 79
Exceptional company quality by Fisher's standards
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 35%
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟢 77
Strong liquidity — would likely survive a real credit squeeze
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 76
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 53
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 51
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 47
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 41
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 37
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 32
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 18
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Based on the last 280 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (0 bullish · 11 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
—
Net Margin
15.3%
EBITDA Margin
—
ROE
29.1%
ROA
11.0%
ROIC
—
EPS
$15.29
Cash
$1.43B
Total Debt
—
Current Ratio
2.16
Debt/Equity
—
אין נתונים היסטוריים זמינים.
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 28.8.2026 | $0.890 |
| 29.5.2026 | $0.890 |
| 28.5.2026 | $0.890 |
| 27.2.2026 | $0.840 |
| 26.2.2026 | $0.840 |
| 28.11.2025 | $0.840 |
| 27.11.2025 | $0.840 |
| 29.8.2025 | $0.840 |
| 28.8.2025 | $0.840 |
| 30.5.2025 | $0.840 |
| 29.5.2025 | $0.840 |
| 28.2.2025 | $0.800 |
How is Fair Value calculated? →
Not enough cash-flow data to calculate a DCF model for this stock.
Book Value per Share
$48.22
Tangible Book Value per Share (Tangible NAV)
$42.03
Sentiment based on basic keywords (not AI) — 13 positive, 4 neutral, 3 negative out of the last 20 articles.
Yahoo · 18.9.2026
Yahoo · 18.9.2026
Yahoo · 18.9.2026
Benzinga · 16.9.2026
Yahoo · 15.9.2026
Yahoo · 14.9.2026
Yahoo · 13.9.2026
24/7 Wall St. · 13.9.2026
Zacks · 11.9.2026
Yahoo · 11.9.2026
StockStory · 11.9.2026
Yahoo · 11.9.2026
MT Newswires · 10.9.2026
Benzinga · 10.9.2026
Yahoo · 9.9.2026
Barchart · 9.9.2026
Zacks · 9.9.2026
Yahoo · 9.9.2026
Yahoo · 7.9.2026
Zacks · 7.9.2026
Evercore Inc. (EVR) currently has a StockIQ AI score of 51/100, rated "Moderate" (a partial score — based on only 6 of 7 categories, some data is currently unavailable). The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
EVR currently scores 51/100 (Moderate) across the categories we measure (a partial score — based on only 6 of 7 categories, some data is currently unavailable). StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
EVR's technical score is 6/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Revenue growth (last year): 29.5%; Earnings per share (EPS) growth: 54.7%; Net income growth: 56.5%.
Based on the real signals StockIQ computed: Calmar: 0.46 (3y annualized return 22.1% / max drawdown 48.2%); Price is below the 50-day average; Price is below the 200-day average.
Yes — EVR has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 2 purchases and 2 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| LaLonde Timothy Gilbert | Open Market Sale | 11.6.2026 | 7,808 | -7,808 | $343.06 |
| LaLonde Timothy Gilbert | Open Market Sale | 11.6.2026 | 34,800 | -7,808 | $343.06 |
| Carlton Pamela G | Grant/Award from Employer | 10.6.2026 | 364 | +364 | — |
| FUTTER ELLEN V | Grant/Award from Employer | 10.6.2026 | 364 | +364 | — |
| Harris Gail Block | Grant/Award from Employer | 10.6.2026 | 364 | +364 | — |
| Robertson Sir Simon | Grant/Award from Employer | 10.6.2026 | 364 | +364 | — |
| MILLARD ROBERT B | Grant/Award from Employer | 10.6.2026 | 815 | +815 | — |
| OVERLOCK WILARD J JR | Grant/Award from Employer | 10.6.2026 | 727 | +727 | — |
| VARNEY CHRISTINE A | Grant/Award from Employer | 10.6.2026 | 727 | +727 | — |
| WHEELER WILLIAM J | Grant/Award from Employer | 10.6.2026 | 364 | +364 | — |
| Williamson Sarah K | Grant/Award from Employer | 10.6.2026 | 727 | +727 | — |
| VARNEY CHRISTINE A | Grant/Award from Employer | 10.6.2026 | 884 | +727 | — |
| MILLARD ROBERT B | Grant/Award from Employer | 10.6.2026 | 53,497 | +815 | — |
| FUTTER ELLEN V | Grant/Award from Employer | 10.6.2026 | 7,312 | +364 | — |
| OVERLOCK WILARD J JR | Grant/Award from Employer | 10.6.2026 | 15,279 | +727 | — |
| WHEELER WILLIAM J | Grant/Award from Employer | 10.6.2026 | 12,642 | +364 | — |
| Carlton Pamela G | Grant/Award from Employer | 10.6.2026 | 3,845 | +364 | — |
| Harris Gail Block | Grant/Award from Employer | 10.6.2026 | 40,151 | +364 | — |
| Robertson Sir Simon | Grant/Award from Employer | 10.6.2026 | 9,715 | +364 | — |
| Williamson Sarah K | Grant/Award from Employer | 10.6.2026 | 14,072 | +727 | — |
| Williamson Sarah K | Open Market Purchase | 6.3.2026 | 2,000 | +2,000 | $290.43 |
| Williamson Sarah K | Open Market Purchase | 6.3.2026 | 13,345 | +2,000 | $290.43 |
| Lindsey-Clark Matthew | Grant/Award from Employer | 19.2.2026 | 7,638 | +7,638 | — |
| LaLonde Timothy Gilbert | Grant/Award from Employer | 19.2.2026 | 12,465 | +12,465 | — |
| Pensa Paul | Grant/Award from Employer | 19.2.2026 | 1,867 | +1,867 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
1,290,059 shares short as of 2026-08-31 · vs. 1,344,390 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
42.5% of trading volume this week was short selling, vs. 53.0% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology